AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

NAHL GROUP PLC

Earnings Release Sep 18, 2018

7805_ir_2018-09-18_fef7935a-b946-4682-b9d6-7a620fced87d.html

Earnings Release

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0302B

NAHL Group PLC

18 September 2018

18 September 2018

NAHL Group plc

("NAHL" or the "Group")

Interim Results

Earnings in line with expectations

NAHL (AIM: NAH), the leading UK consumer marketing business focused on the UK legal services market, announces its Interim Results for the six months ended 30 June 2018.

Financial Highlights

·      Revenue of £24.9m (2017 H1: £24.9m)

·      Underlying operating profit of £6.4m (2017 H1: £7.3m)

·      Profit before tax of £5.3m after exceptional costs relating to the establishment of wholly owned small claims ready law firm or Alternative Business Structure ("ABS") (2017 H1: £5.3m)

·      As anticipated, basic earnings per share of 8.2p (2017 H1: 9.0p)

·      Interim dividend of 3.2p per share (2017 H1: 5.3p) as Group adopts more prudent dividend policy in light of investment plans

Operational Highlights

·      Personal Injury division performing in line with plan, with strong enquiry volumes

·      Encouraging performance from two joint venture ABS partnerships, giving Group confidence to launch in H1 2019 a wholly owned small claims ready law firm

·      Continued strong progress from Critical Care division, with increased revenue and profit

·      Residential Property division performance reflective of continuing difficult wider market conditions

Russell Atkinson, CEO of NAHL, commented:

"We are pleased to have delivered Group earnings in line with expectations, having made good progress in adapting our Personal Injury (PI) division to capture the opportunity to deliver materially enhanced profits over the long-term.

"2018 represents a year of transition for our PI division. The Government's reforms will have no bearing on the number of accidents that occur but it is clear that there is an opportunity for a new type of law firm to help consumers with genuine claims to obtain access to justice. NAH, with its market leading brand and focus on its consumers' experience, is well placed to seize this opportunity.  We have been encouraged by the performance of our two joint venture ABS law firms and are excited about the launch of our third, wholly owned law firm in the first half of 2019. This will give us full economic interest in the success of the whole claim, helping to deliver greater value for our shareholders.

"We are pleased with the performance of our Critical Care division, which has continued to win new business and gain market share. The difficulties facing the housing market have been well documented and this has inevitably impacted our Residential Property division. We have made a leadership change and the division remains well placed to benefit from market recovery.

"As we move forward, our focus is on investing in our PI division to deliver long term growth. As previously indicated we anticipate continued challenges with panel demand for enquiries as a result of regulatory change. As an example, we are in discussion with one of our major PLFs about leaving our panel in H1 2019. We have well developed plans for such a situation which involves placement of enquiries through a combination of PLFs and our joint ventures. We expect to deliver full year earnings in line with the Board's expectations."

For further information please call:

NAHL Group PLC

Russell Atkinson (CEO)

James Saralis (CFO)
via FTI Consulting

Tel: +44 (0) 20 3727 1000
finnCap Ltd (NOMAD & Broker)

Julian Blunt

James Thompson

Andrew Burdis
Tel: +44 (0) 207 220 0500
FTI Consulting (Financial PR)

Alex Beagley

James Styles

Laura Saraby
Tel: +44 (0) 20 3727 1000

Notes to Editors

NAHL Group plc is a leading UK consumer marketing business focused on the UK legal services market. The Group comprises three companies: National Accident Helpline (NAH), Fitzalan Partners (Fitzalan) and Bush & Company Rehabilitation (Bush). NAH provides outsourced marketing services in the personal injury market, Fitzalan, which includes Searches UK a leading conveyancing search provider, provides marketing services in the property market and Bush provides a range of specialist services in the catastrophic injury market.

More information is available at www.nahlgroupplc.co.uk and www.national-accident-helpline.co.uk.

Chairman's Statement

I am pleased to report the Group's results for the six months ended 30 June 2018.

Summary of Financial Performance

NAHL has performed in line with our expectations, with revenue unchanged at £24.9m (2017 H1: £24.9m), delivering underlying operating profit of £6.4m (2017 H1: £7.3m). After exceptional costs, related to the establishment of our third ABS, profit before tax is unchanged at £5.3m (2017 H1: £5.3m, after exceptional brand repositioning costs). In the first half of 2018 we have seen contributions from our first two ABS joint ventures, so consequently have charges for minority interests, meaning that basic earnings per share reduces, as anticipated, to 8.2p (2017 H1: 9.0p).

Trading Review - Personal Injury ("PI")

National Accident Helpline (NAH), part of our PI division, is a leading marketing services business and offers outstanding consumer service. Combining these capabilities with the regulatory changes impacting the sector creates the opportunity for the Group to develop additional earnings streams. So far this has been achieved through joint ventures but in H1 2019 we will launch a wholly owned, modern, digitally enabled, purpose built, small claims ready law firm.

NAH has to date had two options for placement of enquiries.  Firstly, its traditional panel law firms (PLFs) who operate on a mix of commercial terms; and, secondly, its joint venture partnerships (technically, an Alternative Business Structure, or ABS), which benefit from working capital and expertise provided by our partners, who share in the ultimate profit of the joint venture. This placement strategy in part reflects reducing PLF appetite, caused by lower operating margins together with increased working capital requirements, compounded by uncertainties surrounding the small claim reforms. These reforms, first announced in November 2015, are now expected to be implemented in April 2020, at the earliest.

We have invested heavily into these partnerships both in terms of finance and know-how and continue to accelerate this investment. With our expertise, we are in the process of setting up a third placement option and, from H1 2019, some enquiries will be placed with a new ABS which will be 100% owned by the Group. The set up of this third ABS (reflected in the exceptional costs as part of our previously announced £4m commitment) is on schedule and on budget. This new ABS will manage the whole cycle of a PI legal case, with marketing and legal processing profits accruing to the Group. This will continue to change the Group's financial profile as both profit recognition and cash realisation are deferred until case settlement. With our passion for customer service, combined with our process and management capabilities, we expect to earn materially enhanced profits and cash flow as the profile of our cases matures, likely to be from 2021.

The PI division has performed in line with plan in H1 2018. Following our 2017 investment in the NAH brand, enquiry volumes remain strong. PI revenue increased by 4.3% to £15.5m, reflecting the consolidation of £1.7m of ABS revenue, which includes revenue from the launch of the Group's second ABS in Q4 2017. Operating profit was 13.9% lower at £4.6m, as a result of the later profit recognition when we invest in PI case processing, and from expensing £0.6m of enquiry origination costs related to our second ABS. We have continued to increase investment in PI cases, through both PLFs and ABSs, with an extra £5.3m invested in net working capital in the first half, and £10.2m in the last 12 months.

Our first ABS, in conjunction with NewLaw, is operating well, and our second ABS, working with Lyons Davidson, is beginning to show comparable levels of processing capability. We will commit further funds to the ABS as we are confident of their execution capability and economic performance.

As previously outlined, we expect to experience decline in PLF demand as a result of forthcoming regulatory changes. As an example, we are in discussion with one of our major PLFs about leaving our panel in H1 2019. We have well developed plans for such a situation which involves placement of enquiries through a combination of PLFs and our joint ventures. The impact on our overall profit per enquiry is unlikely to be material, although this defers an element of profits from 2019.

Trading Review - Critical Care

Bush, our Critical Care division, has made good progress year on year and is has performed in line with our plans. We expect this to continue for the rest of 2018. Revenue increased 7.3% to £6.0m, and operating profit was up 4.4% to £2.1m.

Trading Review - Residential Property

Our Residential Property division has had a disappointing first half delivering revenue of £3.4m, down 24.5%, with operating profit down 27.0% at £0.6m, reflecting continuing difficult market conditions. We have made leadership changes aimed at capitalising on opportunities to grow share in a shrinking market.

Cash Conversion, Balance Sheet and Interim Dividend

As we continue to invest in PI cases and working capital, our cash generation declines, as planned, with underlying cash conversion down at 20.3% compared with 54.8% for H1 2017. We expect a low conversion, albeit improved from the first half, for the rest of 2018, with some recovery in 2019 as our earlier investment in PI cases starts to mature.

We have bank facilities of £25m in place and at 30 June 2018 had net bank borrowings of £17.4m. Our Rolling Credit Facility, which matures in December 2021, supports our investment plans.

As we previously reported, the level of our investment means that we have adopted a more prudent dividend policy until our PI investment cycle matures. Our dividend policy is 2.0x cover, before exceptional costs and non-cash charges.

We are declaring an interim dividend of 3.2p per share payable on 31 October 2018 to ordinary shareholders registered on 28 September 2018.

Current Year Outlook

As expected, 2018 is part of a transitional phase for our PI division as we respond to changing market conditions and evolve our enquiry placement strategies. We continue to invest in our joint ventures and develop our own law firm which are progressing well. We are enthused about building a market leading PI volume law firm to complement our market leading PI marketing services brand, National Accident Helpline.

We expect progress in Critical Care in the second half, although we expect further challenges in Residential Property where market volumes continue to be disappointing.

We currently anticipate 2018 earnings to be in line with the Board's expectations for the Group as a whole.

Steve Halbert

Chairman

18 September 2018

Consolidated statement of comprehensive income

for the 6 months ended 30 June 2018

Note Unaudited

6 months

ended 30

June 2018

£000
Unaudited

6 months

ended 30

June 2017

£000
Audited

12 months

ended 31

December 2017

£000
Underlying revenue 2 24,865 24,930 51,037
Exceptional items - - 875
Total revenue 24,865 24,930 51,912
Cost of sales (12,217) (12,014) (25,224)
Underlying gross profit 12,648 12,916 25,813
Exceptional items - - 875
Gross profit 12,648 12,916 26,688
Administrative expenses (7,269) (7,504) (14,086)
Underlying operating profit 6,360 7,347 14,491
Share-based payments (191) (281) (182)
Amortisation of intangible assets acquired on business combinations 7 (648) (654) (1,307)
Exceptional items 5 (142) (1,000) (400)
Total operating profit 2 5,379 5,412 12,602
Financial income 3 98 38 150
Financial expense 4 (206) (166) (331)
Profit before tax 5,271 5,284 12,421
Taxation (953) (1,187) (2,467)
Profit for the period and total comprehensive income 4,318 4,097 9,954
Profit and total comprehensive income is attributable to:
Owners of the company 3,758 4,097 9,876
Non-controlling interests 560 - 78
4,318 4,097 9,954
Unaudited 6 months ended

30 June 2018
Unaudited 6 months

ended

30 June

2017
Audited 12 months

ended 

31 December 2017
Basic earnings per share (p) 10 8.2 9.0 21.7
Diluted earnings per share (p) 10 8.0 8.9 21.6

Consolidated statement of financial position

At 30 June 2018

Note Unaudited 6 months ended 30 June 2018

£000
Unaudited 6 months ended 30 June 2017

£000
Audited 12 months ended 31 December 2017

£000
Non-current assets
Goodwill 6 60,362 60,362 60,362
Intangibles 7 6,647 7,783 7,217
Property, plant and equipment 225 290 267
Deferred tax asset 34 38 34
67,268 68,473 67,880
Current assets
Trade and other receivables (including £9,538,000 (June 2017: £2,041,000, December 2017: £7,280,000) due in greater than one year) 29,978 14,142 22,261
Cash and cash equivalents 939 799 858
30,917 14,941 23,119
Total assets 98,185 83,414 90,999
Current liabilities
Other interest-bearing loans and borrowings - (3,693) -
Trade and other payables (14,770) (9,360) (12,415)
Other payables relating to legacy pre-LASPO ATE product 2 (865) (2,026) (676)
Deferred tax liability (1,500) (1,914) (1,662)
Tax payable (1,290) (1,432) (1,513)
(18,425) (18,425) (16,266)
Non-current liabilities
Other interest-bearing loans and borrowings (18,334) (6,550) (12,922)
Total liabilities (36,759) (24,975) (29,188)
Net assets 61,426 58,439 61,811
Equity
Share capital 8 115 114 115
Share option reserve 2,312 2,220 2,121
Share premium 14,595 14,507 14,507
Merger reserve (66,928) (66,928) (66,928)
Retained earnings 110,756 108,526 111,893
Total equity attributable to the owners of NAHL Group plc 60,850 58,439 61,708
Non-controlling interests 576 - 103
Total equity 61,426 58,439 61,811

Consolidated statement of changes in equity

for the 6 months ended 30 June 2018

Share

capital

£000
Share

option

reserve

£000
Share

premium

£000
Merger

reserve

£000
Retained

earnings

£000
Total

 £000
Non-controlling interest

£000
Total

equity

£000
Balance at 1 January 2018 115 2,121 14,507 (66,928) 111,893 61,708 103 61,811
Total comprehensive income for the period
Profit for the period - - - - 3,758 3,758 560 4,318
Total comprehensive income - - - - 3,758 3,758 560 4,318
Transactions with owners, recorded directly in equity
Issue of new Ordinary Shares (note 9) - - 88 - - 88 - 88
Share-based payments - 191 - - - 191 - 191
Dividends paid - - - - (4,895) (4,895) - (4,895)
Non- controlling interest member drawings - - - - - - (87) (87)
Balance at 30 June 2018 115 2,312 14,595 (66,928) 110,756 60,850 576 61,426
Balance at 1 January 2017 113 1,939 14,507 (66,928) 110,188 59,819 - 59,819
Total comprehensive income for the period
Profit for the period - - - - 4,097 4,097 - 4,097
Total comprehensive income - - - - 4,097 4,097 4,097
Transactions with owners, recorded directly in equity
Issue of new Ordinary shares (note 9) 1 - - - - 1 - 1
Share-based payments - 281 - - - 281 - 281
Dividends paid - - - - (5,759) (5,759) - (5,759)
Balance at 30 June 2017 114 2,220 14,507 (66,928) 108,526 58,439 - 58,439
Balance at 1 January 2017 113 1,939 14,507 (66,928) 110,188 59,819 - 59,819
Total comprehensive income for the year
Profit for the year - - - - 9,876 9,876 78 9,954
Total comprehensive income - - - - 9,876 9,876 78 9,954
Transactions with owners, recorded directly in equity
Issue of new Ordinary Shares (note 9) 2 - - - - 2 - 2
Member capital - - - - - - 25 25
Share-based payments - 182 - - - 182 - 182
Dividends paid - - - - (8,171) (8,171) - (8,171)
Balance at 31 December 2017 115 2,121 14,507 (66,928) 111,893 61,708 103 61,811

Consolidated cash flow statement

for the 6 months ended 30 June 2018

Note Unaudited 6 months ended 30 June 2018

£000
Unaudited

6 months ended 30 June 2017 £000
Audited

12 months ended 31 December 2017

£000
Cash flows from operating activities
Profit for the period 4,318 4,097 9,954
Adjustments for:
Depreciation and amortisation 810 808 1,608
Financial income 3 (98) (38) (150)
Financial expense 4 206 166 331
Share-based payments 191 281 182
Taxation 953 1,187 2,467
6,380 6,501 14,392
Increase in trade and other receivables (7,621) (3,822) (11,974)
Increase in trade and other payables 2,340 1,713 4,963
Increase/(decrease) in other payables relating to legacy pre-LASPO ATE product 189 114 (1,236)
Cash generation from operations 2 1,288 4,506 6,145
Interest paid (154) (121) (178)
Tax paid (1,338) (1,692) (3,139)
Net cash from operating activities (204) 2,693 2,828
Cash flows from investing activities
Acquisition of property, plant and equipment (42) (80) (111)
Acquisition of intangible assets (156) - (305)
Interest received 2 5 12
Non-controlling interest member capital - - 25
Net cash used in investing activities (196) (75) (379)
Cash flows from financing activities
New share issue 88 1 2
Repayment of borrowings - (1,875) (11,250)
New borrowings acquired 5,375 1,000 13,125
Bank arrangement fees for new borrowings - - (111)
Dividends paid (4,895) (5,759) (8,171)
Non- controlling interest member drawings (87) - -
Net cash used in financing activities 481 (6,633) (6,405)
Net increase/(decrease) in cash and cash equivalents 81 (4,015) (3,956)
Cash and cash equivalents at beginning of period 858 4,814 4,814
Cash and cash equivalents at end of period 939 799 858

Notes to the financial statements

1. Accounting policies

General Information

The half year results for the current and comparative period to 30 June have not been audited or reviewed by auditors pursuant to the Auditing Practices Board guidance of Review of Interim Financial Information.

These half year results do not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2017 were approved by the Board of Directors on 19 March 2018 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 498 of the Companies Act 2006.

Having made due enquiries the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future.  For this reason, they continue to adopt the going concern basis in preparing the condensed set of financial statements.

The condensed set of financial statements was approved by the Board of Directors on 17 September 2018.

Basis of preparation

Statement of compliance

The half year results for the current and comparative period to 30 June have been prepared in accordance with IAS 34 Interim Financial Reporting as adopted by the EU and the AIM Rules of UK companies.  They do not include all of the information required for full annual financial statements and should be read in conjunction with the financial statements of the Group for the year ended 31 December 2017, which have been prepared in accordance with IFRSs as adopted by the European Union.

New and amended standards adopted by the Group

The following new or amended standards became applicable for the current reporting period:

IFRS 9 - Financial Instruments

IFRS 15 - Revenue from Contracts with Customers

The Group has considered its accounting policies with reference to the new or amended standards and concluded that the existing accounting policies adopted by the Group adhere to the new or amended standards. There are therefore no retrospective adjustments to be made to amounts previously reported.

Use of judgements and estimates

The preparation of financial statements in conformity with IFRSs requires management to make judgements and estimates that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the year in which the estimates are revised and in any future years affected.

The preparation of the condensed set of financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and reported amounts of assets and liabilities, income and expense.  Actual results may differ from these estimates.

In preparing the condensed set of financial statements, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were of the same type as those that applied to the financial statements for the year ended 31 December 2017.

Significant accounting policies

The accounting policies used in the preparation of these interim financial statements for the 6 months ended 30 June 2018 are the accounting policies as applied to the Group's financial statements for the year ended 31 December 2017.

Use of non-GAAP measures

The Directors believe that underlying operating profit, underlying revenue and underlying operating cash provide additional useful information for shareholders on underlying trends and performance. These measures are used by management for performance analysis and are considered useful as they relate to the core underlying trading activities of the Group i.e. they reflect the current ongoing activities of the Group and do not include any items that relate to significant exceptional projects that are not expected to recur or any items that relate to activities that are outside the normal course of trading (e.g. acquisitions or share-based costs that are not directly related to the current operating performance of the Group). Underlying operating profit, underlying revenue and underlying operating cash are not defined by IFRS and therefore may not be directly comparable to other companies' adjusted profit, revenue, cash or debt measures. They are not intended to be a substitute for, or superior to IFRS measurements.

The adjustments made to reported revenue are:

Exceptional revenues - fees related to exceptional revenues in relation to release of the pre-LASPO ATE liability that are not expected to recur and are not related to the continuing core operations of the business.

The adjustments made to reported operating profit are:

IFRS 2 Share-Based Payments - non-cash Group statement of comprehensive income charge for share-based payments and related National Insurance costs. IFRS 2 requires the fair value of equity instruments measured at grant date to be spread over the period during which the employees become unconditionally entitled to the options. This is a non-cash charge and has been excluded from underlying operating profit as it does not reflect the underlying core trading performance of the Group.

IFRS 3 (Revised) Business Combinations - intangible asset amortisation charges and costs arising from acquisitions. Under IFRS 3 intangible assets are required to be amortised on a straight-line basis over their useful economic life and as such this is a non-cash charge that does not reflect the underlying performance of the business acquired. Similarly, the standard requires all acquisition costs to be expensed in the Group Income Statement. Due to their nature, these costs have been excluded from underlying operating profit as they do not reflect the underlying core trading performance of the Group.

Other exceptional costs/income - these relate to certain exceptional costs associated with the Group's acquisition activities including any costs in relation to aborted acquisitions, reorganisation costs associated with exceptional projects that are not related to the core operations of the business, set up costs of new Group entities including new alternative business structures and exceptional income for the release of previously recognised liability for pre-LASPO ATE. These have been excluded from underlying operating profit as they do not reflect the underlying core trading performance of the Group.

Goodwill

Goodwill represents the excess of the fair value of the consideration given over the fair value of the Group's share of the net identifiable assets of the acquired subsidiary at the date of acquisition.  Goodwill is not amortised but is tested for impairment annually and again whenever indicators of impairment are detected and is carried at cost less any provision for impairment. Any impairment is recognised in the statement of comprehensive income.

Other intangible assets

Other intangible assets that are acquired by the Group and have finite useful lives are measured at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Intangible assets are amortised on a straight-line basis over their estimated useful lives as follows:

•               Technology related intangibles               -               5 to 10 years

•               Contract related intangibles                    -               3 to 10 years

•               Brand names                                           -               3 to 10 years

•               Other intangibles assets                         -               3 to 5 years

No amortisation is charged on assets under construction as these are not yet in use.

Depreciation

Depreciation is calculated to write off the cost, less estimated residual value, of property, plant and equipment by equal instalments over their estimated useful economic lives as follows:

•               Office equipment                     -               3 to 5 years

•               Computers                               -               3 years

2. Operating segments

Personal Injury

£000
Critical

Care

£000
Residential Property

£000
Group

£000
Underlying operations £000 Pre-LAPSO ATE        £000 Other

  items

£000
Total

£000
6 months ended 30 June 2018
Revenue 15,489 5,970 3,406 - 24,865 - - 24,865
Depreciation and amortisation (94) (18) (50) - (162) - (648) (810)
Operating profit/(loss) 4,622 2,087 588 (937) 6,360 - (981) 5,379
Financial income 97 - - 1 98 - - 98
Financial expenses - - - (206) (206) - - (206)
Profit/(loss) before tax 4,719 2,087 588 (1,142) 6,252 - (981) 5,271
Trade receivables 14,572 4,655 795 - 20,022 - - 20,022
Segment liabilities (12,492) (1,003) (569) (706) (14,770) (865)1 - 15,635
Capital expenditure 21 20 157 - 198 - - 198
6 months ended 30 June 2017
Revenue 14,854 5,564 4,512 - 24,930 - - 24,930
Depreciation and amortisation (91) (32) (31) - (154) - (654) (808)
Operating profit/(loss) 5,371 2,000 805 (829) 7,347 - (1,935) 5,412
Financial income 36 - - 2 38 - - 38
Financial expenses - (2) - (164) (166) - - (166)
Profit/(loss) before tax 5,407 1,998 805 (991) 7,219 - (1,935) 5,284
Trade receivables 4,117 4,210 499 - 8,826 - - 8,826
Segment liabilities (6,884) (885) (984) (492) (9,245) (2,026)1 (115) (11,386)
Capital expenditure 33 27 20 - 80 - - 80
12 months ended 31 December 2017
Revenue 31,660 11,037 8,340 - 51,037 875 - 51,912
Depreciation and amortisation (178) (49) (74) - (301) - (1,307) (1,608)
Operating profit/(loss) 11,033 3,882 1,385 (1,809) 14,491 800 (2,689) 12,602
Financial income 143 5 - 2 150 - - 150
Financial expenses (1) (4) - (326) (331) - - (331)
Profit/(loss) before tax 11,175 3,883 1,385 (2,133) 14,310 800 (2,689) 12,421
Trade receivables 11,442 4,386 419 - 16,247 - - 16,247
Segment liabilities (10,453) (806) (506) (600) (12,365) (726)1 - (13,091)
Capital expenditure 53 47 191 - 291 - - 291

1.          Pre-LASPO ATE liabilities include the balance of commissions received in advance that are due to be paid back to the insurance  

provider of £865,000 (June 2017: £2,026,000, December 2017: £676,000 plus associated accrued costs of £50,000).

Geographic information

All revenue and assets of the Group are based in the UK.

Operating segments

The activities of the Group are managed by the Board, which is deemed to be the chief operating decision maker (CODM). The CODM has identified the following segments for the purpose of performance assessment and resource allocation decisions. These segments are split along product lines and consistent with those reported last year.

Personal Injury - Revenue from the provision of enquiries to the PLFs, based on a cost plus margin model, plus commissions received from providers for the sale of additional products by them to the PLFs and in the case of the ABSs, revenue receivable from clients for the provision of legal services.

Pre-LASPO ATE - Revenue is commissions received from the insurance provider for the use of after the event policies by PLFs. From 1 April 2013, this product was no longer available as a result of LASPO regulatory changes. Included in the balance sheet is a liability that has been separately identified due to its material value. This balance is commissions received in advance that are due to be paid back to the insurance provider. No interest is due on this liability.

Critical Care - Revenue from the provision of expert witness reports and case management support within the medico-legal framework for multi-track cases.

Residential Property - Revenue from the provision of online marketing services to target homebuyers and sellers in England and Wales, offering lead generation services to PLFs and surveyors in the conveyancing sector and the provision of conveyancing searches for solicitors and licensed conveyancers.

Group - Costs that are incurred in managing Group activities or not specifically related to a product.

Other items  - Costs associated with the acquisition of subsidiary undertakings, reorganisation costs associated with one-off projects that are not related to the core operations of the business, share-based payments and amortisation charges on intangible assets recognised as part of business combinations.

Cash flows from operating activities

A reconciliation of operating profit to cash generation from operations has been presented below separately identifying net cash flows relating to underlying operations (comprising cash flows associated with Personal Injury, Critical Care, Residential Property and other segments), the Pre- LASPO ATE product segment and other items.

Reconciliation of operating profit to net cash flows from operating activities

Underlying operations

£000
Pre-LASPO

ATE

£000
Sub-total

£000
Other items

£000
Total

£000
6 months ended 30 June 2018
Operating profit 5,521 - 5,521 (142) 5,379
Amortisation of intangible assets acquired on business combinations 648 - 648 - 648
Equity-settled share-based payments 191 - 191 - 191
Underlying operating profit 6,360 - 6,360 (142) 6,218
Depreciation and amortisation 162 - 162 - 162
(Increase) in trade/other receivables (7,621) - (7,621) - (7,621)
Increase/(decrease) in trade/other payables 2,390 (50) 2,340 - 2,340
Increase in liabilities relating to pre-LASPO ATE product - 189 189 - 189
Net cash flows from operating activities before interest and tax 1,291 139 1,430 (142) 1,288
Interest paid (154) - (154) - (154)
Tax paid (1,338) - (1,338) - (1,338)
Net cash from operating activities (201) 139 (62) (142) (204)
6 months ended 30 June 2017
Operating profit 6,412 - 6,412 (1,000) 5,412
Amortisation of intangible assets acquired on business combinations 654 - 654 - 654
Equity-settled share-based payments 281 - 281 - 281
Underlying operating profit 7,347 - 7,347 (1,000) 6,347
Depreciation and amortisation 154 - 154 - 154
(Increase) in trade/other receivables (3,822) - (3,822) - (3,822)
Increase/(decrease) in trade/other payables 1,668 (70) 1,598 115 1,713
Increase in liabilities relating to pre-LASPO ATE product - 114 114 - 114
Net cash flows from operating activities before interest and tax 5,347 44 5,391 (885) 4,506
Interest paid (121) - (121) - (121)
Tax paid (1,692) - (1,692) - (1,692)
Net cash from operating activities 3,534 44 3,578 (885) 2,693
12 months ended 31 December 2017
Operating profit 13,002 800
Amortisation of intangible assets acquired on business combinations 1,307 -
Equity-settled share-based payments 182 -
Underlying operating profit 14,491 800
Depreciation and amortisation 301 -
(Increase) in trade/other receivables (11,974) -
Increase/(decrease) in trade/other payables 5,120 (20)
Decrease in liabilities relating to pre-LASPO ATE product - (1,236)
Net cash flows from operating activities before interest and tax 7,938 (456)
Interest paid (178) -
Tax paid (3,139) -
Net cash from operating activities 4,621 (456)

3. Financial income

Unaudited 6 months ended 30 June 2018

£000
Unaudited 6 months ended 30 June 2017

£000
Audited 12 months ended 31 December 2017

£000
Bank interest income 2 5 6
Other interest income 96 33 139
Investment income - - 5
Total finance income 98 38 150

4. Financial expense

Unaudited 6 months ended 30 June 2018

£000
Unaudited 6 months ended 30 June 2017

£000
Audited 12 months ended 31 December 2017

£000
Interest on bank loans 169 135 257
Amortisation of facility arrangement fees 37 31 74
Total finance expense 206 166 331

5. Exceptional items

Unaudited 6 months ended 30 June 2018

£000
Unaudited 6 months ended 30 June 2017

£000
Audited 12 months ended 31 December 2017

£000
Set up costs for new ABS1 (142) - -
Personal Injury reorganisation costs2 - (1,000) (1,200)
Release of pre-LASPO ATE liability and associated costs3 - - 800
Total (142) (1,000) (400)

1.     Set up costs for new ABS include legal and professional fees, consultancy fees, IT costs and other directly attributable costs that 

are wholly necessary to bring the new alternative business structure into operational existence. 

2.    Personal Injury reorganisation costs relate to costs associated with exceptional projects that are not related to the core operations   

of the business.

3.     Previously recognised liabilities for pre-LASPO ATE commissions received in advance of £875,000 were released in 2017 as a result of more favourable settlements. These have been offset by associated costs of £75,000.

6. Goodwill

Personal Injury

£000
Residential

property

£000
Critical

Care

£000
Total

£000
Cost
At 30 June 2017 39,897 4,873 15,592 60,362
At 30 December 2017 39,897 4,873 15,592 60,362
At 30 June 2018 39,897 4,873 15,592 60,362
Impairment
At 30 June 2017 - - - -
At 30 December 2017 - - - -
At 30 June 2018 - - - -
Net book value
At 30 June 2017 39,897 4,873 15,592 60,362
At 30 December 2017 39,897 4,873 15,592 60,362
At 30 June 2018 39,897 4,873 15,592 60,362

7. Intangibles

Technology related

£000
Contract related

£000
Brand names

£000
Other

£000
Assets under construction

£000
Total

£000
Cost
At 30 June 2017 167 8,466 885 549 43 10,110
At 31 December 2017 167 8,466 885 670 79 10,267
Additions - - - 32 124 156
At 30 June 2018 167 8,466 885 702 203 10,423
Amortisation
At 30 June 2017 52 1,824 364 87 - 2,327
At 31 December 2017 62 2,363 468 157 - 3,050
Amortisation charge on business combinations 10 538 100 - - 648
Amortisation charge for the period - - - 78 - 78
At 30 June 2018 72 2,901 568 235 - 3,776
Net book value
At 30 June 2017 115 6,642 521 462 43 7,783
At 31 December 2017 105 6,103 417 513 79 7,217
At 30 June 2018 95 5,565 317 467 203 6,647

The intangible assets recognised were acquired as part of the acquisitions of Fitzalan, BVC, Bush and Searches UK.

8. Share capital

30 June 2018 30 June 2017 31 December 2017
Number of shares
'A' Ordinary Shares of £0.0025 each 46,178,716 45,511,088 46,061,090
£000 £000 £000
Allotted, called up and fully paid
'A' Ordinary Shares of £0.0025 each 115 114 115
Shares classified in equity 115 114 115

9. Transactions with owners, recorded directly in equity

During 2017, 711,461 share options were exercised which resulted in the issue of 711,461 new ordinary shares with a par value of

£0.0025. The exercising of these options raised funds of £1,779 for the Group.

During 2018, 117,626 share options were exercised from the LTIP and SAYE schemes which resulted in the issue of 117,626 new ordinary shares with a par value of £0.0025. The exercising of these options raised funds of £88,356 for the Group and resulted in an increase to the share premium account of £88,062.

10. Earnings per share

The calculation of basic earnings per share at 30 June 2018 is based on profit attributable to ordinary shareholders and a weighted average number of Ordinary Shares outstanding at the end of the period as follows:

Profit attributable to ordinary shareholders (basic)

Unaudited 6 months ended 30 June

2018

£000
Unaudited 6 months ended 30 June

2017

£000
Audited 12 months ended 31 December  2017

£000
Profit for the period attributable to the shareholders 3,758 4,097 9,876

Weighted average number of Ordinary Shares (basic)

Number Unaudited 6 months ended

30 June 2018
Unaudited 6 months ended 30 June 2017 Audited 12 months ended 31 December 2017
Issued Ordinary Shares at start of period 46,061,090 45,349,629 45,349,629
Weighted average number of Ordinary Shares at end of period 46,100,876 45,350,071 45,548,243

Basic earnings per share (p)

Unaudited 6 months ended 30 June 2018 Unaudited 6 months ended 30 June 2017 Audited 12 months ended 31 December 2017
Group (p) 8.2 9.0 21.7

The Company has in place share-based payment schemes to reward employees. The incremental shares available for these schemes included in the diluted earnings per share calculation are 958,388 (June 2017: 602,503; December 2017: 205,303). There are no other diluting items.

Diluted earnings per share (p)

Unaudited 6 months ended 30 June 2018 Unaudited    6 months ended 30 June 2017 Audited 12 months ended 31 December

 2017
Group (p) 8.0 8.9 21.6

11. Financial risk management

The Group's financial risk management objectives and policies are consistent with those disclosed in the financial statements for the year ended 31 December 2017. At 1 January 2018 and 30 June 2018 the Group held all financial instruments at Level 3 (as defined in IFRS 7 Financial instruments: disclosures) and there have been no transfers of assets or liabilities between levels of the fair value hierarchy.

12. Net debt

Net debt includes cash and cash equivalents, secured bank loans, loan notes and preference shares.

30 June 2018

£000
30 June

2017

£000
31 December 2017

£000
Cash and cash equivalents 939 799 858
Other interest-bearing loans and loan notes1 (18,334) (10,243) (12,922)
Net debt (17,395) (9,444) (12,064)

1.   Other interest-bearing loans and loan notes are stated after deducting facility arrangement fees of £166,000 (June 2017: £132,000, December 2017: £203,000). These fees are being amortised over the term of the facility.

Set out below is a reconciliation of movements in net debt during the period.

30 June 2018

£000
30 June

2017

£000
31 December 2017

£000
Net increase/(decrease) in cash and cash equivalents 81 (4,015) (3,956)
Cash and cash equivalents net inflow from increase in debt and debt financing (5,412) 846 (1,833)
Movement in net borrowings resulting from cash flows (5,331) (3,169) (5,789)
Movement in net debt in period (5,331) (3,169) (5,789)
Net debt at beginning of period (12,064) (6,275) (6,275)
Net debt at end of period (17,395) (9,444) (12,064)

The Group refinanced its bank facilities on the 8 September 2017. During the first half of 2018 the Group made further drawdowns of £5,375,000 on its rolling credit facility. It is the Group's intention to repay the balance on the rolling credit facility in more than 12 months time and hence the gross balance of £18,500,000 is deemed to be a non-current liability.

13. Related parties

Transactions with key management personnel

Key management personnel in situ at 30 June 2018 and their immediate relatives control 3.1 per cent (June 2017: 4.1 per cent, December 2017: 4.5 per cent) of the voting shares of the Company.

Key management personnel are considered to be the Directors of the Company as well as those of National Accident Helpline Limited, Fitzalan Partners Limited, Bush & Company Rehabilitation Limited, Searches UK Limited and any other management serving as part of the executive team.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IR EAKNXFALPEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.